Simcere Pharmaceutical Group Limited
2096
주식 순위
#4479
Simcere Pharmaceutical Group Limited is a Chinese entity engaged in the... Simcere Pharmaceutical Group Limited is a Chinese entity engaged in the comprehensive process of discovering, developing, manufacturing, and commercializing pharmaceutical products. These medicines are distributed to various clients, including distributors, pharmacy chains, and fellow drug manufacturers within China. The company strategically focuses on a diverse range of therapeutic areas, notably oncology, central nervous system conditions, autoimmune diseases, anti-infective treatments, and cardiovascular health, among others. Its extensive product portfolio features key medications such as Sanbexin (an edaravone and dexborneol concentrated solution for injection), Endostar (a recombinant human endostatin injection), ENWEIDA (an envafolimab injection), Softan (rosuvastatin calcium tablets), ZAILIN (amoxicillin in granules, dispersible tablets, or capsules), Iremod (iguratimod tablets), Antine (diclofenac sodium sustained-release capsules or gel), and Orencia (an abatacept injection). Additionally, Simcere offers specialized promotional services for pharmaceutical goods. Demonstrating its commitment to innovation, the group has established a strategic regional licensing collaboration with Vivoryon Therapeutics N.V. This partnership aims to develop and commercialize novel therapies for Alzheimer's disease by targeting the neurotoxic amyloid protein N3pE (pGlu-Aß). Established in 1995, Simcere Pharmaceutical Group Limited is headquartered in Nanjing, China.
주가
$1.32
시가총액
$3.40B
변동 (1일)
-4.51%
변동 (1년)
-19.88%
국가
CN
거래 Simcere Pharmaceutical Group Limited (2096)
카테고리
Healthcare
Simcere Pharmaceutical Group Limited (2096)의 배당 이력
Simcere Pharmaceutical Group Limited (주식 심볼: 2096)은 총 6회의 배당금을 지급했습니다.
모든 배당금의 합계 (주식 분할 반영): $1.09
배당 수익률 (TTM): 0.0199
모든 배당금의 합계 (주식 분할 반영): $1.09
배당 수익률 (TTM): 0.0199
Simcere Pharmaceutical Group Limited (2096)의 2021부터 2026까지 배당 지급 내역
연간 배당 지급
| 연도 | 배당금 (주식 분할 조정됨) | 변화 |
|---|---|---|
| 2026 (TTM) | $0.2069 | 18.36% |
| 2025 | $0.1748 | -0.51% |
| 2024 | $0.1757 | -0.06% |
| 2023 | $0.1758 | 0.06% |
| 2022 | $0.1757 | -2.55% |
| 2021 | $0.1803 | 0.00% |
모든 배당 지급 목록
| 연도 | 배당금 | 변화 |
|---|---|---|
| 2026 (TTM) | $0.2069 | 18.36% |
| 2025 | $0.1748 | -0.51% |
| 2024 | $0.1757 | -0.06% |
| 2023 | $0.1758 | 0.06% |
| 2022 | $0.1757 | -2.55% |
| 2021 | $0.1803 | 0.00% |
유사 기업 또는 경쟁사의 배당 지급
| 회사 | 배당 지급 횟수 | 국가 |
|---|---|---|
| 0.00% |
US
|
|
| 0.00% |
US
|
|
| 67.00% |
AU
|
|
| 30.00% |
BE
|
|
| 0.00% |
NL
|
